Neurim Pharmaceuticals Switzerland

Neurim Pharmaceuticals Ltd. is a drug discovery and development company, focused on the central nervous system (CNS), primarily in age-related disorders.

Circadin®, the company’s novel product for insomnia, was approved by the European Commission on the 29th June 2007 and is currently marketed in Europe, Asia-Pacific, Latin America, Africa and the Middle East. Other products are NCEs at preclinical and clinical development.

Neurim Pharmaceuticals was founded in 1991 by Prof. Nava Zisapel, a recognized neuroscientist and by the entrepreneur and businessman Mr. Yehuda Zisapel, who is also founder and director of the RAD Group, a high-tech group specializing in data communication and chairman of Rad-Biomed, a biomedical start-up incubator.